Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy

por Jacoberger-Foissac, Celia, Blake, Stephen J, Liu, Jing, McDonald, Elizabeth, Triscott, Hannah, Nakamura, Kyohei, Smyth, Mark J, Teng, Michele WL
Publicado 2020

Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma

por Allard, Bertrand, Jacoberger-Foissac, Célia, Cousineau, Isabelle, Bareche, Yacine, Buisseret, Laurence, Chrobak, Pavel, Allard, David, Pommey, Sandra, Ah-Pine, Franck, Duquenne, Sebastien, Picard, Fabien, Stagg, John
Publicado 2023